<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">32312103</PMID><DateCompleted><Year>2021</Year><Month>08</Month><Day>31</Day></DateCompleted><DateRevised><Year>2021</Year><Month>08</Month><Day>31</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2167-9223</ISSN><JournalIssue CitedMedium="Internet"><Volume>21</Volume><Issue>5-6</Issue><PubDate><Year>2020</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Amyotrophic lateral sclerosis &amp; frontotemporal degeneration</Title><ISOAbbreviation>Amyotroph Lateral Scler Frontotemporal Degener</ISOAbbreviation></Journal><ArticleTitle>Electrical impedance myography (EIM) in a natural history study of <i>C9ORF72</i> mutation carriers.</ArticleTitle><Pagination><StartPage>445</StartPage><EndPage>451</EndPage><MedlinePgn>445-451</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1080/21678421.2020.1752247</ELocationID><Abstract><AbstractText><i>Objective:</i> Electrical Impedance Myography (EIM) was used to evaluate disease progression in subjects with <i>C9ORF72</i> expansion mutations and to assess correlations with Medical Research Council (MRC) Scale and revised ALS Functional Rating Scale (ALSFRS-R) measurements. Four types of clinical presentations were assessed; Amyotrophic Lateral Sclerosis (ALS), Frontotemporal dementia (FTD) or other dementia, ALS-FTD, and asymptomatic (ASYMP). <i>Methods:</i> Subjects were divided into an ALS Group (ALS/ALS-FTD) and non-ALS Group (FTD/ASYMP) based on initial visit and evaluated at 0, 6, 18, and 30 months with EIM of 4 arm and 4 leg muscles, ALSFRS-R, and MRC scales. The change in EIM from baseline and correlation with the functional scale and strength testing were analyzed. <i>Results:</i> EIM 50kHz phase values significantly declined over time in the ALS group (<i>n</i>&#x2009;=&#x2009;31) compared to the non-ALS group (FTD/ASYMP) (<i>n</i>&#x2009;=&#x2009;19). In the ALS group, the decline in EIM was correlated with decline in the ALSFRS-R and MRC scores using within-subject correlations. <i>Conclusion:</i> In clinical trials with small populations of genetically associated ALS such as <i>C9ORF</i>-related ALS, EIM may be a useful quantitative biomarker. We did not detect decline in asymptomatic subjects, but longer term studies may detect early changes in this group.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Offit</LastName><ForeName>Michelle B</ForeName><Initials>MB</Initials><AffiliationInfo><Affiliation>EMG Section, NINDS, NIH, Bethesda, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Tianxia</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Clinical Trials Unit, NINDS, NIH, Bethesda, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Floeter</LastName><ForeName>Mary Kay</ForeName><Initials>MK</Initials><AffiliationInfo><Affiliation>Motor Neuron Disorders Unit, NINDS, NIH, Bethesda, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lehky</LastName><ForeName>Tanya J</ForeName><Initials>TJ</Initials><AffiliationInfo><Affiliation>EMG Section, NINDS, NIH, Bethesda, MD, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>Z99 NS999999</GrantID><Acronym>ImNIH</Acronym><Agency>Intramural NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052060">Research Support, N.I.H., Intramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>04</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Amyotroph Lateral Scler Frontotemporal Degener</MedlineTA><NlmUniqueID>101587185</NlmUniqueID><ISSNLinking>2167-8421</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000073885">C9orf72 Protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C568651">C9orf72 protein, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000073885" MajorTopicYN="N">C9orf72 Protein</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017097" MajorTopicYN="N">Electric Impedance</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057180" MajorTopicYN="Y">Frontotemporal Dementia</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009213" MajorTopicYN="N">Myography</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">C9ORF72 gene mutation</Keyword><Keyword MajorTopicYN="N">Electrical Impedance Myography (EIM)</Keyword><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis (ALS)</Keyword><Keyword MajorTopicYN="N">frontotemporal dementia</Keyword><Keyword MajorTopicYN="N">neuromuscular disorders</Keyword></KeywordList><CoiStatement><b>Disclosure of Conflicts of Interest:</b> &#x201c;None of the authors has any conflict of interest to disclose.&#x201d;</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>4</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>9</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>4</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32312103</ArticleId><ArticleId IdType="mid">NIHMS1729331</ArticleId><ArticleId IdType="pmc">PMC8340645</ArticleId><ArticleId IdType="doi">10.1080/21678421.2020.1752247</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Chia R, Chio A, Traynor BJ. Novel genes associated with amyotrophic lateral sclerosis: diagnostic and clinical implications. Lancet Neurol 2018;17:94&#x2013;102.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5901717</ArticleId><ArticleId IdType="pubmed">29154141</ArticleId></ArticleIdList></Reference><Reference><Citation>Mok K, Traynor BJ, Schymick J, et al. Chromosome 9 ALS and FTD locus is probably derived from a single founder. Neurobiol Aging 2012;33:209 e203&#x2013;208.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3312749</ArticleId><ArticleId IdType="pubmed">21925771</ArticleId></ArticleIdList></Reference><Reference><Citation>Renton AE, Chio A, Traynor BJ. State of play in amyotrophic lateral sclerosis genetics. Nat Neurosci 2014;17:17&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4544832</ArticleId><ArticleId IdType="pubmed">24369373</ArticleId></ArticleIdList></Reference><Reference><Citation>Renton AE, Majounie E, Waite A, et al. A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron 2011;72:257&#x2013;268.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3200438</ArticleId><ArticleId IdType="pubmed">21944779</ArticleId></ArticleIdList></Reference><Reference><Citation>Floeter MK, Bageac D, Danielian LE, Braun LE, Traynor BJ, Kwan JY. Longitudinal imaging in C9orf72 mutation carriers: Relationship to phenotype. Neuroimage Clin 2016;12:1035&#x2013;1043.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5153604</ArticleId><ArticleId IdType="pubmed">27995069</ArticleId></ArticleIdList></Reference><Reference><Citation>Floeter MK, Traynor BJ, Farren J, et al. Disease progression in C9orf72 mutation carriers. Neurology 2017;89:234&#x2013;241.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5513817</ArticleId><ArticleId IdType="pubmed">28615433</ArticleId></ArticleIdList></Reference><Reference><Citation>Murphy NA, Arthur KC, Tienari PJ, Houlden H, Chio A, Traynor BJ. Age-related penetrance of the C9orf72 repeat expansion. Sci Rep 2017;7:2116.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5437033</ArticleId><ArticleId IdType="pubmed">28522837</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams KL, Fifita JA, Vucic S, et al. Pathophysiological insights into ALS with C9ORF72 expansions. J Neurol Neurosurg Psychiatry 2013;84:931&#x2013;935.</Citation><ArticleIdList><ArticleId IdType="pubmed">23463871</ArticleId></ArticleIdList></Reference><Reference><Citation>Rutkove SB. Electrical impedance myography: Background, current state, and future directions. Muscle &amp; nerve 2009;40:936&#x2013;946.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2824130</ArticleId><ArticleId IdType="pubmed">19768754</ArticleId></ArticleIdList></Reference><Reference><Citation>Rutkove SB, Caress JB, Cartwright MS, et al. Electrical impedance myography correlates with standard measures of ALS severity. Muscle Nerve 2014;49:441&#x2013;443.</Citation><ArticleIdList><ArticleId IdType="pubmed">24273034</ArticleId></ArticleIdList></Reference><Reference><Citation>Nichols C, Jain MS, Meilleur KG, et al. Electrical impedance myography in individuals with collagen 6 and laminin alpha-2 congenital muscular dystrophy: a cross-sectional and 2-year analysis. Muscle Nerve 2018;57:54&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6383203</ArticleId><ArticleId IdType="pubmed">28224647</ArticleId></ArticleIdList></Reference><Reference><Citation>Rutkove SB, Caress JB, Cartwright MS, et al. Electrical impedance myography as a biomarker to assess ALS progression. Amyotroph Lateral Scler 2012;13:439&#x2013;445.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3422377</ArticleId><ArticleId IdType="pubmed">22670883</ArticleId></ArticleIdList></Reference><Reference><Citation>Rutkove SB, Darras BT. Electrical impedance myography for the assessment of children with muscular dystrophy: a preliminary study. J Phys Conf Ser 2013;434.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3721184</ArticleId><ArticleId IdType="pubmed">23894248</ArticleId></ArticleIdList></Reference><Reference><Citation>Rutkove SB, Shefner JM, Gregas M, et al. Characterizing spinal muscular atrophy with electrical impedance myography. Muscle Nerve 2010;42:915&#x2013;921.</Citation><ArticleIdList><ArticleId IdType="pubmed">21104866</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanchez B, Rutkove SB. Electrical Impedance Myography and Its Applications in Neuromuscular Disorders. Neurotherapeutics 2017;14:107&#x2013;118.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5233633</ArticleId><ArticleId IdType="pubmed">27812921</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanchez B, Rutkove SB. Present Uses, Future Applications, and Technical Underpinnings of Electrical Impedance Myography. Curr Neurol Neurosci Rep 2017;17:86.</Citation><ArticleIdList><ArticleId IdType="pubmed">28933017</ArticleId></ArticleIdList></Reference><Reference><Citation>Rutkove SB, Fogerson PM, Garmirian LP, Tarulli AW. Reference values for 50-kHZ electrical impedance myography. Muscle Nerve 2008;38:1128&#x2013;1132.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2535900</ArticleId><ArticleId IdType="pubmed">18642375</ArticleId></ArticleIdList></Reference><Reference><Citation>Cedarbaum JM, Stambler N, Malta E, et al. The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III). J Neurol Sci 1999;169:13&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pubmed">10540002</ArticleId></ArticleIdList></Reference><Reference><Citation>Ludolph A, Drory V, Hardiman O, et al. A revision of the El Escorial criteria - 2015. Amyotroph Lateral Scler Frontotemporal Degener 2015;16:291&#x2013;292.</Citation><ArticleIdList><ArticleId IdType="pubmed">26121170</ArticleId></ArticleIdList></Reference><Reference><Citation>Rascovsky K, Hodges JR, Knopman D, et al. Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain 2011;134:2456&#x2013;2477.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3170532</ArticleId><ArticleId IdType="pubmed">21810890</ArticleId></ArticleIdList></Reference><Reference><Citation>Beasley WC. Instrumentation and equipment for quantitative clinical muscle testing. Arch Phys Med Rehabil 1956;37:604&#x2013;621.</Citation><ArticleIdList><ArticleId IdType="pubmed">13363575</ArticleId></ArticleIdList></Reference><Reference><Citation>Dyck PJ, Boes CJ, Mulder D, et al. History of standard scoring, notation, and summation of neuromuscular signs. A current survey and recommendation. J Peripher Nerv Syst 2005;10:158&#x2013;173.</Citation><ArticleIdList><ArticleId IdType="pubmed">15958127</ArticleId></ArticleIdList></Reference><Reference><Citation>Bland JM, Altman DG. Calculating correlation coefficients with repeated observations: Part 2--Correlation between subjects. BMJ 1995;310:633.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2549010</ArticleId><ArticleId IdType="pubmed">7703752</ArticleId></ArticleIdList></Reference><Reference><Citation>Kortman HG, Wilder SC, Geisbush TR, Narayanaswami P, Rutkove SB. Age- and gender-associated differences in electrical impedance values of skeletal muscle. Physiol Meas 2013;34:1611&#x2013;1622.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3895401</ArticleId><ArticleId IdType="pubmed">24165434</ArticleId></ArticleIdList></Reference><Reference><Citation>Aaron R, Esper GJ, Shiffman CA, Bradonjic K, Lee KS, Rutkove SB. Effects of age on muscle as measured by electrical impedance myography. Physiol Meas 2006;27:953&#x2013;959.</Citation><ArticleIdList><ArticleId IdType="pubmed">16951455</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>